Correction: Predicting Antituberculosis Drug-Induced Liver Injury Using an Interpretable Machine Learning Method:
Tao Zhong1, Zian Zhuang2,3,4, Xiaoli Dong5,6
1Department of Tuberculosis Control, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China.
JMIR Medical Informatics
|August 16, 2021
Summary
This study corrects a previously published article DOI. The correction ensures accurate citation and retrieval of scientific research for improved data integrity.
Area of Science:
- Bibliometrics
- Scientific Publishing
- Research Integrity
Context:
- Correction of a previously assigned Digital Object Identifier (DOI).
- Ensuring accurate referencing in scientific literature.
- Maintaining the integrity of the scientific record.
Purpose:
- To provide the correct DOI for the article.
- To facilitate proper citation and access to the research.
- To rectify an error in the publication's metadata.
Summary:
- The article DOI 10.2196/29226 has been corrected.
- This ensures that readers and indexing services can accurately locate the intended publication.
- The correction supports the reliability of scientific communication.
Impact:
- Improved discoverability of the research article.
- Enhanced accuracy in academic referencing and citation tracking.
- Upholding standards of scientific publishing and data management.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
37
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
37
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
119
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
119
Pulmonary Tuberculosis IV
245
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
245
Pulmonary Tuberculosis V
274
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
274
Therapeutic Drug Monitoring: Affecting Factors
34
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
34
Therapeutic Drug Monitoring: Drug Analysis Methods
32
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
32


